- CSR Summary Not Yet Available
- NCT00230698
- Primary Citation
- Data Specification Not Available
Trial Information
Generic NameTopiramateProduct NameTOPAMAX®Therapeutic AreaNervous System DiseasesEnrollment451% Female52%% WhiteN/A
Product ClassAnticonvulsantsSponsor Protocol NumberTOPMAT-EPMN-104Data PartnerJohnson & JohnsonCondition StudiedEpilepsyMean/Median Age (Years)36.5
Supporting Documentation
- Collected Datasets Available
- Protocol with Amendments Available
- Statistical Analysis Plan Available
- Clinical Study Report Available